Both AOD 9604 and tirzepatide have been through human trials, but the depth and outcome of those trials could not be more different
In summary, the key interactions to consider are pyridoxines reduction of levodopa and anticonvulsant efficacy, niacinamides additive effects on blood pressure, blood sugar, and gout management, and the potential need for B-vitamin repletion in patients on certain medications (diuretics, isoniazid, etc.)
Antioxidant Activity: It neutralizes free radicals, unstable molecules that can damage cells and accelerate aging, thus protecting tissues from oxidative stress
Clinical evidence by peptide and dose varies, with some trials showing hormonal shifts as well as tissue effects
Benefits: By reducing inflammation, BPC-157 can offer relief from the stiffness and discomfort that often accompany joint pain
PMID 14279251